EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Clinical Evidence and Mechanistic Plausibility of Chinese Patent Medicines for Sepsis: An Evidence Map

Qingsong Liu, Mengyao Zheng, Zichen Wang iD, Yifei He, Jiayue Xu, Wen Wang, Xin Sun

Journal of Inflammation Research · 2026-09 · Volume 19 · 1-17

DOI: 10.2147/jir.s635181 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Qingsong Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Integrated Traditional Chinese and Western Medicine, Chinese Evidence-Based Medicine Center and Cochrane China Center, West China Hospit…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a life-threatening syndrome with limited specific therapeutic options. Chinese patent medicines (CPMs) are widely used as adjunctive therapies in China, although the available clinical evidence, predominantly from injectable formulations, remains fragmented. This evidence map integrated review-level clinical evidence with in vivo findings to assess evidence certainty and mechanistic plausibility. Eighteen meta-analyses and 337 eligible animal studies were identified; 237 animal studies corresponding to interventions with at least one moderate-certainty clinical outcome entered the focused mechanistic analysis. No review-outcome estimate was rated as high certainty, and 27 of 152 review-outcome estimates (17.8%) were rated as moderate certainty. Moderate-certainty evidence was concentrated mainly in Xuebijing and Shenfu, with fewer moderate-certainty signals for Shengmai, Shenmai, Yiqifumai, Shuxuetong, and Xiyanping. In animal models, Xuebijing and Shenfu were associated with inflammatory and immune regulation, endothelial or barrier protection, mitochondrial function, and programmed cell death, while Shengmai, Shenmai, and Yiqifumai showed more limited pathway-level associations involving oxidative stress, cardiovascular protection, and ferroptosis. Overall, the animal evidence suggested overlapping biological pathways, but risk of bias was generally unclear or high and did not establish causal mechanisms in humans. This evidence map provides a structured framework linking clinical evidence certainty with mechanistic plausibility and highlights important evidence gaps. Given the limited certainty of the clinical evidence, these findings should be considered hypothesis-generating and require confirmation in rigorous clinical trials, systematic safety evaluations, and methodologically robust translational studies.

Schlagwörter

Stichwörter der Autor:innen

Chinese patent medicineGRADEevidence mapmechanistic plausibilitysepsissystematic review

Autor:innen und Institutionen

  • Institute of Integrated Traditional Chinese and Western Medicine, Chinese Evidence-Based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
  • NMPA Key Laboratory for Real-World Data Research and Evaluation in Hainan, Chengdu, Sichuan, People's Republic of China.
  • Sichuan Center of Technology Innovation for Real-World Data, Chengdu, Sichuan, People's Republic of China.
  • NHC Key Laboratory of Clinical Epidemiology and Evidence-Based Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
  • Center of Real-World Research and Evaluation for Healthcare Security, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

ORCID-Profile: Zichen Wang

Zitieren

APA

Liu, Q., Zheng, M., Wang, Z., He, Y., Xu, J., Wang, W., & Sun, X. (2026). Clinical Evidence and Mechanistic Plausibility of Chinese Patent Medicines for Sepsis: An Evidence Map. Journal of Inflammation Research, Volume 19, 1-17. https://doi.org/10.2147/jir.s635181

Vancouver

Liu Q, Zheng M, Wang Z, He Y, Xu J, Wang W, et al. Clinical Evidence and Mechanistic Plausibility of Chinese Patent Medicines for Sepsis: An Evidence Map. Journal of Inflammation Research. 2026;Volume 19:1-17. doi:10.2147/jir.s635181

BibTeX
@article{Liu2026,
  author = {Liu, Qingsong and Zheng, Mengyao and Wang, Zichen and He, Yifei and Xu, Jiayue and Wang, Wen and Sun, Xin},
  title = {Clinical Evidence and Mechanistic Plausibility of Chinese Patent Medicines for Sepsis: An Evidence Map},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--17},
  doi = {10.2147/jir.s635181}
}
Kostenlos starten →